HealthLiraglutide Safely Lowers Cardiovascular Risk By 13 Percent In Patients With Type 2 Diabetes After almost four years of clinical trials, a study on liraglutide has finally concluded. Results showed that the injectable drug can reduce cardiovascular risk by 13 percent in patients with type 2 diabetes, without any serious adverse effects.by Catherine Cabral-Isabedra
HealthEating At Least Four Servings Of Whole Grains Increases Life Span: Studyby Catherine Cabral-Isabedra
HealthOver Half Of Patients Prescribed With Opioid Painkillers Receive Extra, Many Share Themby Katherine Derla
HealthStudy Finds Link Between Kids Exposed To Domestic Violence And Suicide Attemptsby Alyssa Navarro
HealthVaping Teens More Likely To Become Regular Cigarette Smokers: Studyby Catherine Cabral-Isabedra